Purchase Order 36C26220P0220
Award Date 11/22/19
Potential Completion Date 11/30/20
Potential Value $82K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a $174,000.00 Firm Fixed Price contract to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products, for off-site research and development of knockout cell pools. The contract supports the VA's research efforts, but does not have a set-aside designation. Through this award, Synthego will provide customized cell clones, cell lines, induced pluripotent stem cells,...
- This is a $60,132.50 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for the provision of a Whole Human Genome Arrayed CRISPR Screening Library to support NCATS' translational science research efforts. This award is not associated with a...
- This is a $25,150.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR genome engineering and related services to support biomedical research efforts across multiple NIH institutes. Synthego specializes in custom cell line development, gene...
- This is a $88,310 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR gene editing services to develop five different induced pluripotent stem (iPS) cell lines expressing fluorescent proteins or HiBiT tags at specific target genes. This is a non-competitive award under...
- This is a $146,665.75 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of goods. The contract was not set aside. Synthego, headquartered in Redwood City, California, is providing genome engineering solutions, including cell line engineering, CRISPR libraries, and other biological...
- The National Human Genome Research Institute (NHGRI), a civilian agency within the Department of Health and Human Services, has awarded a $86,750.00 firm fixed price purchase order to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products located in Redwood City, California. The contract is for CRISPR gene-editing of the ACVR1 and TGFBR1 genes in endometrial cancer cell lines to support NHGRI's research objectives. This contract was...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Synthego Corporation, a self-certified small disadvantaged business, for $188,840.00 to provide gene editing services. The contract is for the delivery of GMP-like CRISPRevolution modified single guide RNA (mod-sgRNA) sequences to support ongoing research within the LCIM program. The agency determined Synthego to...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for the development of induced pluripotent stem (iPS) report cell lines expressing HiBiT at specified target genes. The $235,150.00 contract has a 20-24 week period of performance and does not have a set-aside designation. The work will be performed at Synthego's...
- This is a federal contract award by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The contract is a $46,600 firm fixed-price purchase order with a completion date of November 15, 2020. The contract does not have a set-aside designation. Synthego specializes in providing genome engineering solutions, including...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Purchase Order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of KNOCKIN-SMALL, CELL CLONE, IMMORTALIZED with a potential value of $12,950.00. This order is part of Synthego's extensive portfolio of federal contracts to provide gene editing products, cell line engineering, and research support services...